ReWalk Robotics (NASDAQ:RWLK) Now Covered by Analysts at StockNews.com

StockNews.com started coverage on shares of ReWalk Robotics (NASDAQ:RWLK) in a research report sent to investors on Wednesday morning. The firm issued a sell rating on the medical device company’s stock.

ReWalk Robotics Price Performance

The business has a 50 day moving average of $0.93 and a 200 day moving average of $0.79. ReWalk Robotics has a 12 month low of $0.56 and a 12 month high of $1.30. The company has a market capitalization of $63.04 million, a price-to-earnings ratio of -2.84 and a beta of 2.30.

Hedge Funds Weigh In On ReWalk Robotics

Several hedge funds and other institutional investors have recently modified their holdings of the company. Mercer Global Advisors Inc. ADV lifted its holdings in ReWalk Robotics by 208.3% in the 3rd quarter. Mercer Global Advisors Inc. ADV now owns 44,403 shares of the medical device company’s stock worth $34,000 after purchasing an additional 30,000 shares in the last quarter. Renaissance Technologies LLC purchased a new position in shares of ReWalk Robotics in the first quarter worth $35,000. Virtu Financial LLC boosted its position in shares of ReWalk Robotics by 249.6% during the fourth quarter. Virtu Financial LLC now owns 47,638 shares of the medical device company’s stock worth $36,000 after acquiring an additional 34,013 shares during the last quarter. Millennium Management LLC increased its holdings in ReWalk Robotics by 42.9% in the 4th quarter. Millennium Management LLC now owns 139,009 shares of the medical device company’s stock valued at $106,000 after acquiring an additional 41,753 shares during the last quarter. Finally, Kent Lake Capital LLC purchased a new stake in ReWalk Robotics in the 4th quarter worth $532,000. 3.58% of the stock is owned by institutional investors.

ReWalk Robotics Company Profile

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic.